Journal profile · CHEMISTRY, MEDICINAL-PHARMACOLOGY & PHARMACY
Pharmaceutical Chemistry Journal
ISSN 0091-150X · eISSN 1573-9031 · Springer US · United States · Monthly · Founded 1967
Pharmaceutical Chemistry Journal: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.72; subscription journal; review 3–8 weeks (community reports); community-reported acceptance: easy; 197 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Pharmaceutical Chemistry Journal is published by Springer US and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Synthesis and biological activity, Synthesis and Characterization of Heterocyclic Compounds and Analytical Chemistry and Chromatography, together about 35.3% of its articles. Its main subfields are Organic Chemistry. (generated from OpenAlex topic counts and CAS ranking data)
Pharmaceutical Chemistry Journal is a monthly publication devoted to scientific and technical research on the creation of new drugs and the improvement of manufacturing technology of drugs and intermediates. International contributors cover the entire spectrum of new drug research, including: methods of synthesis;results of pharmacological, toxicological, and biochemical studies;investigation of structure - activity relationships in prediction of new compounds;methods and technical facilities used; andproblems associated with the development of ecologically safe and economically feasible methods of industrial production. In addition, analytical reviews of the international literature in the field provide coverage of the most recent developments around the world.Pharmaceutical Chemistry Journal is a translation of the Russian journal Khimiko-Farmatsevticheskii Zhurnal. The Russian Volume Year is published in English from April.All articles are peer-reviewed.
From the journal's Aims & Scope
Research area (LetPub): CHEMISTRY, MEDICINAL-PHARMACOLOGY & PHARMACY
Editor-in-chief Nikolay L. ShimanovskyPublisher website
Editorial board by country: none in mainland China; most named Russia 32, United States 1, Greece 1, Ukraine 1 (35 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Synthesis and biological activityChemistry14.3%
- Synthesis and Characterization of Heterocyclic CompoundsChemistry11.7%
- Analytical Chemistry and ChromatographyChemistry9.4%
- Synthesis and Reactions of Organic CompoundsChemistry8.5%
- Synthesis and Biological EvaluationChemistry5.2%
- Analytical Methods in PharmaceuticalsChemistry4.5%
- Synthesis and Reactivity of Sulfur-Containing CompoundsChemistry4.2%
- Chemical synthesis and pharmacological studiesChemistry3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Chemistry, Medicinal | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Chemistry, Medicinal | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Chemistry, Medicinal | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EmbaseCASPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, AGRICOLA, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 0.72LetPub ·
- Impact factor (publisher) 2025
- 0.8Publisher website ·
- 5-year impact factor (publisher) 2025
- 0.9Publisher website ·
- CiteScore 2026-06
- 1.6LetPub ·
- SJR 2026-06
- 0.21LetPub ·
- SNIP 2026-06
- 0.33LetPub ·
- h-index
- 26LetPub ·
- h-index
- 48OpenAlex ·
- i10-index
- 843OpenAlex ·
- 2-year mean citedness
- 1.21OpenAlex ·
- Self-citation rate
- 12.5%LetPub ·
- Share of gold OA articles
- 0.15%LetPub ·
Volume
- Articles per year
- 190LetPub ·
- Downloads per year (publisher) 2025
- 143,300Publisher website ·
Articles by year OpenAlex count · 12,724 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 25 | 2 | 3 |
| 2025 | 197 | 3 | 155 |
| 2024 | 254 | 9 | 419 |
| 2023 | 253 | 13 | 664 |
| 2022 | 260 | 23 | 1,150 |
| 2021 | 218 | 11 | 978 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- 3–8 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Peer review
- Single anonymous peer review, Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
Article types accepted2
- editorialSingle-blind peer review This journal follows a single-blind reviewing procedure. Additional information This journal is guided by the Springer Portfolio editor…Length not stated
- reviewBefore a publication decision is made, your manuscript will be reviewed by at least two independent, anonymous peers in the field, in addition to the assigned e…Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, Peer review
- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability
Data transparency Model summary
All authors are requested to make sure that all data and materials as well as software application or custom code support their published claims and comply with field standards.
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
COPE member Model summary
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- Peer review SUBMISSION & REVIEW PROCESS
Single-blind peer review Model summary
MANUSCRIPT SUBMISSION Manuscripts should be submitted online to http://chem.folium.ru/index.php/chem This web-based manuscript management system offers easy and straightforward login and submission procedures. It also allows you to track the progress of manuscript review in real time. Manuscripts not obeying the above rules may be returned for revision, correction, or abridging. Please return the …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer US
- Country or region
- United States
- Language
- English
- Frequency
- Monthly
- Founded
- 1967
- ISSN
- 0091-150X
- Electronic ISSN
- 1573-9031
- Latest issue on the website
- Volume 59, Issue 11 (February 2026)
- Official links
- Journal homepage ↗OpenAlex
- Author guidelines ↗LetPub
FAQ
Frequently asked questions about Pharmaceutical Chemistry Journal
What CAS zone is Pharmaceutical Chemistry Journal in?
In the 2025 upgraded edition of the CAS Journal Ranking, Pharmaceutical Chemistry Journal is in Zone 4 of Medicine, and in Zone 4 of the minor category Chemistry, Medicinal / Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Pharmaceutical Chemistry Journal?
The latest impact factor listed by LetPub is 0.72; CiteScore 1.6, h-index 48.
How long does peer review take at Pharmaceutical Chemistry Journal?
Authors report an average review time of 3–8 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Pharmaceutical Chemistry Journal?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Reference style: Numbered, in order of citation; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Pharmaceutical Chemistry Journal based?
Of the 35 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Russia (32), United States (1) and Greece (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Pharmaceutical Chemistry Journal?
According to LetPub and DOAJ records, Pharmaceutical Chemistry Journal is indexed in SCIE and Scopus. The journal's website also lists Embase and CAS; that list has not been checked against each database.
Is Pharmaceutical Chemistry Journal open access, and what is the APC?
Pharmaceutical Chemistry Journal is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .